| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Buckwheat Sprouts — edible young seedlings produced by germination of buckwheat, principally common buckwheat (Fagopyrum esculentum) and Tartary buckwheat (Fagopyrum tataricum). They are a flavonoid- and polyphenol-rich functional food rather than a standardized drug or single-molecule therapeutic. Common buckwheat sprouts characteristically contain rutin, orientin, isoorientin, vitexin, isovitexin, quercetin-related glycosides, chlorogenic acid and other phenolic compounds, whereas Tartary buckwheat sprouts are generally more rutin-dominant and can contain substantially higher rutin concentrations. Germination markedly alters the phytochemical profile relative to ungerminated grain. Composition varies with species, sprouting duration, illumination, cultivar and cultivation conditions. Buckwheat sprouts also contain the phototoxic naphthodianthrone derivatives fagopyrins, making excessive consumption of green sprouts potentially more problematic than consumption of buckwheat grain. Primary mechanisms (ranked):
Bioavailability / PK relevance: Buckwheat sprouts are a complex food matrix and do not have a single definable pharmacokinetic profile. Rutin has relatively poor absorption as intact rutin and largely reaches the colon, where microbial metabolism produces quercetin and other metabolites that subsequently enter the circulation. Human pharmacokinetic studies demonstrate delayed and highly variable systemic exposure after rutin-containing foods. The C-glycosyl flavones orientin, isoorientin, vitexin and isovitexin contribute additional exposure but their concentrations vary substantially among sprout preparations. Consequently, phytochemical content cannot be directly converted into systemic therapeutic exposure. In-vitro vs systemic exposure relevance: Concentrated methanolic, ethanolic, polyphenol-rich or subcritical-water sprout extracts used in many cell studies can produce concentrations substantially different from those achievable by eating ordinary fresh sprouts. Cancer-cell and mechanistic extract studies should therefore not be interpreted as demonstrating equivalent systemic anticancer activity from dietary consumption. Food-level effects are more plausibly mediated by repeated intestinal exposure, metabolites and modulation of antioxidant, inflammatory and metabolic pathways. Clinical evidence status: Predominantly preclinical and nutritional. Evidence includes compositional studies, biochemical assays, cultured-cell studies and animal models of inflammation, oxidative stress, dyslipidemia and hypertension. Direct randomized human therapeutic trials of buckwheat sprouts themselves are sparse or absent in the literature identified, and there is no established clinical anticancer indication. Buckwheat sprouts should therefore be classified as a functional food / preclinical nutraceutical rather than an established treatment. Safety is generally compatible with food use, but large or repetitive consumption of green sprouts may increase fagopyrin exposure and risk of photosensitization; one experimental assessment proposed keeping fresh sprout intake below approximately 40 g/day, although a validated human toxicological threshold has not been established. Major Bioactive Ingredients in Buckwheat Sprouts
Harvest interpretation: Approximately day 3 favors maximum concentrations of the C-glycosyl flavones isoorientin, orientin, isovitexin and vitexin. Approximately day 6 provides a better overall compromise because rutin and total measured phenols peak at this stage. In one common buckwheat study, total phenols reached 162.9 mg/100 g fresh weight at day 6. Tartary Buckwheat Sprout Flour Compared with Fresh Sprouts
Practical interpretation: Tartary buckwheat sprout flour is a concentrated and convenient alternative to fresh sprouts, particularly when rutin is the primary target. Freeze-dried or gently dried sprout powder is preferable because excessive heat can reduce flavonoid content. Sprout flour should not be confused with ordinary Tartary buckwheat grain flour, which generally contains substantially less rutin. Buckwheat Sprout Mechanisms
|
| Source: HalifaxProj(inhibit) |
| Type: |
| Cyclooxygenase-2 (COX-2) is an enzyme that plays a critical role in the conversion of arachidonic acid to prostaglandins, which are lipid compounds involved in various physiological processes, including inflammation, pain, and fever. COX-2 is an inducible enzyme, meaning its expression is typically low in normal tissues but can be upregulated in response to inflammatory stimuli, growth factors, and certain oncogenic signals. -Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin biosynthesis, plays a key role in inflammation and circulatory homeostasis. -COX-2 is an inducible enzyme that is upregulated in response to pro-inflammatory signals, including cytokines (e.g., IL-1β, TNF-α) and growth factors. COX-2 is often overexpressed in various tumors, including colorectal, breast, lung, and prostate cancers. The prostaglandins produced by COX-2, particularly prostaglandin E2 (PGE2), have several effects that can facilitate cancer progression: Cell Proliferation: PGE2 can promote the proliferation of cancer cells by activating signaling pathways such as the PI3K/Akt and MAPK pathways. Nonselective NSAIDs, such as aspirin and ibuprofen, inhibit both COX-1 and COX-2. Epidemiological studies have suggested that regular use of NSAIDs may reduce the risk of certain cancers, particularly colorectal cancer. Drugs specifically targeting COX-2, such as celecoxib, have been developed. COX-2 and xanthine oxidase are ROS-producing pro-oxidant enzymes that contribute to inflammation. Elevated COX‑2 levels, often found in inflammatory conditions or certain types of cancers, can contribute to increased production of ROS. |
| 7946- | BuckWS, | Extract of buckwheat sprouts scavenges oxidation and inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages (RAW264.7) |
| - | Study, | Nor, | NA |
| 7951- | RT, | BuckWS, | The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:470 Target#:66 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid